Catalent to build biologics plant at former GE Healthcare facility
US contractor Catalent Pharma Solutions’ new biologics plant will be a facility formerly owned by GE Healthcare.
In December Catalent announced plans to boost biologics production capacity by moving operations from its plant in Middleton, Wisconsin to neighbouring Madison to a site which – according to a report in last week's Wisconsin State Journal – was previously operated by GE’s bone scanning tech unit, Lunar.
Facility general manager told the paper the move will more than double the company's space, from 40,000 square feet to 100,000 square feet, and roughly quadruple manufacturing capacity.
Jenkins added that the remodelling work and additional construction required to convert the plant will be completed later this year with the aim of brining the facility online early in 2013.
